Effect of dopamine on regional myocardial function and oxygen consumption in experimental left ventricular hypertrophy

1991 ◽  
Vol 86 (5) ◽  
pp. 449-460 ◽  
Author(s):  
C. Wright ◽  
H. R. Weiss ◽  
J. Kedem ◽  
P. M. Schooz
Keyword(s):  
Oxygen Consumption ◽  
Left Ventricular Hypertrophy ◽  
Ventricular Hypertrophy ◽  
Myocardial Function ◽  
Left Ventricular ◽  
Regional Myocardial Function

scholarly journals 974-40 Ventricular and Myocardial Function Following Regression of Hypertensive Left Ventricular Hypertrophy

1995 ◽  
Vol 25 (2) ◽  
pp. 251A ◽  
Author(s):  
Gerard P. Aurigemma ◽  
John S. Gottdiener ◽  
William H. Gaasch ◽  
David Williams ◽  
Zahid Jamal ◽  
...  
Keyword(s):  
Left Ventricular Hypertrophy ◽  
Ventricular Hypertrophy ◽  
Myocardial Function ◽  
Left Ventricular

scholarly journals Postoperative reversibility of left ventricular hypertrophy and myocardial function in aortic valvular disease.

1990 ◽  
Vol 54 (5) ◽  
pp. 563-567 ◽  
Author(s):  
SUSUMU NAKANO ◽  
KAZUHIRO TANIGUCHI ◽  
TOMOHIDE KAWAMOTO ◽  
MASATAKA MITSUNO ◽  
HIKARU MATSUDA ◽  
...  
Keyword(s):  
Left Ventricular Hypertrophy ◽  
Ventricular Hypertrophy ◽  
Myocardial Function ◽  
Left Ventricular ◽  
Valvular Disease

scholarly journals Differentiating Pathological from Physiological Left Ventricular Hypertrophy by Quantifying Myocardial Function

2014 ◽  
Vol 46 ◽  
pp. 21-21 ◽  
Author(s):  
A Decloedt ◽  
S Ven ◽  
N Van Der Vekens ◽  
D De Clercq ◽  
G van Loon
Keyword(s):  
Left Ventricular Hypertrophy ◽  
Ventricular Hypertrophy ◽  
Myocardial Function ◽  
Left Ventricular

Catecholamines, Blood Pressure, Renin and Myocardial Function in the Spontaneously Hypertensive Rat

1976 ◽  
Vol 51 (s3) ◽  
pp. 455s-459s
Author(s):  
Suzanne Oparil ◽  
Lynda Erinoff ◽  
A. Cutilletta
Keyword(s):  
Blood Pressure ◽  
Left Ventricular Hypertrophy ◽  
Ventricular Hypertrophy ◽  
Myocardial Function ◽  
Spontaneously Hypertensive Rat ◽  
Plasma Renin ◽  
Left Ventricular ◽  
Ventricular Contractility ◽  
Spontaneously Hypertensive ◽  
6 Hydroxydopamine

1. Neither nerve-growth-factor antiserum (NGFAS) administered subcutaneously nor 6-hydroxydopamine administered intraventricularly to immature spontaneously hypertensive rats (SHR) inhibited the development of the hypertensive syndrome. In contrast, NGFAS did not affect blood pressure in normotensive Kyoto/Wistar rats. 2. Peripheral vascular resistance was increased and cardiac index decreased in both NGFAS and 6-hydroxydopamine-treated SHR despite preservation of normal blood pressure. 3. NGFAS treatment did not influence the development of left ventricular hypertrophy in SHR, despite the lowering of blood pressure. In contrast, 6-hydroxydopamine caused an attenuation in the development of left ventricular hypertrophy. 4. Indices of left ventricular contractility were depressed by NGFAS treatment but not by 6-hydroxydopamine. 5. Plasma renin activity was unaffected by NGFAS treatment and increased by 6-hydroxydopamine.

Sign in / Sign up

Export Citation Format

Share Document